Mudanças no Programa de Tratamento de Dependência de Opioides: Implicações para o Acesso e Arranjos Transicionais

An Australian Alcohol and other Drugs Council (AADC) and Australian Injecting and Illicit Drug Users League (AIVL) online event

In the May 2023 Federal Budget, it was announced that from 1 July 2023 the more than 50,000 Australians who need treatment for opioid dependency will have funded support to access the treatment they need from their local pharmacy at a cost they can afford, through a $377.3 million investment over 4 years in the Pharmaceutical Benefits Scheme (PBS) Opioid Dependence Treatment program (ODTP). The resultant changes and transitional arrangements will be outlined and discussed at this event, with the online audience having an opportunity to ask any questions arising ahead of implementation.

Programa

• Welcome, Acknowledgement of Country and introduction to event
  Melanie Walker, CEO, AADC
• Introduction to AIVL, its current work and strategic priorities
  John G, CEO, AIVL
• Outline of ODTP changes and transitional arrangements from 1 July 2023
  David Laffan, Assistant Secretary, Pharmacy Branch, Australian Government Department of Health and Aged Care
• Forum with panellists and audience participation to discuss the changes and transitional arrangements.